Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Pharmacogenet Genomics. 2010 Jul;20(7):407–413. doi: 10.1097/FPC.0b013e328338bac2

Table 5.

Comparison of individuals who were either wild-type for *2, *3, *6, *7, *9, *11, *12, and *18, or had a variant genotype at any of these alleles

CYP2C9 (*2–*18) Number Average dose ± SE Comparison Value
Homozygous WT at all SNPs 61 40.2 ± 2.2 P value 0.00018
Heterozygous at any 41 28.5 ± 1.5 Adjusted R2 12%

SNP, single nucleotide polymorphism; WT, wild-type.